NO20091642L - [2-(6-fluor-1H-indol-3-ylsulfanyl)benzyl]metylamin for behandling av affektive lidelser - Google Patents

[2-(6-fluor-1H-indol-3-ylsulfanyl)benzyl]metylamin for behandling av affektive lidelser

Info

Publication number
NO20091642L
NO20091642L NO20091642A NO20091642A NO20091642L NO 20091642 L NO20091642 L NO 20091642L NO 20091642 A NO20091642 A NO 20091642A NO 20091642 A NO20091642 A NO 20091642A NO 20091642 L NO20091642 L NO 20091642L
Authority
NO
Norway
Prior art keywords
ylsulfanyl
indol
methylamine
fluoro
benzyl
Prior art date
Application number
NO20091642A
Other languages
English (en)
Inventor
Jan Kehler
Karsten Juhl
Neil Anderson
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2007/000419 external-priority patent/WO2008037258A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20091642L publication Critical patent/NO20091642L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

[2-(6-fluor-1H-indol-3-ylsulfanyl)benzyl]metylamin og farmasøytisk akseptable salter derav, forutsatt at det ikke er den frie basen i en ikke-krystallinsk form, tilveiebringes for behandlingen av affektive lidelser.
NO20091642A 2006-09-28 2009-04-27 [2-(6-fluor-1H-indol-3-ylsulfanyl)benzyl]metylamin for behandling av affektive lidelser NO20091642L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200601251 2006-09-28
DKPA200700432 2007-03-20
PCT/DK2007/000419 WO2008037258A1 (en) 2006-09-28 2007-09-27 [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders

Publications (1)

Publication Number Publication Date
NO20091642L true NO20091642L (no) 2009-04-27

Family

ID=40225153

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091642A NO20091642L (no) 2006-09-28 2009-04-27 [2-(6-fluor-1H-indol-3-ylsulfanyl)benzyl]metylamin for behandling av affektive lidelser

Country Status (8)

Country Link
KR (1) KR20090074749A (no)
AR (1) AR062981A1 (no)
BR (1) BRPI0717038A2 (no)
CL (1) CL2007002789A1 (no)
EA (1) EA200970325A1 (no)
IL (1) IL197720A0 (no)
NO (1) NO20091642L (no)
TW (1) TW200829550A (no)

Also Published As

Publication number Publication date
KR20090074749A (ko) 2009-07-07
BRPI0717038A2 (pt) 2013-10-01
EA200970325A1 (ru) 2009-12-30
AR062981A1 (es) 2008-12-17
TW200829550A (en) 2008-07-16
CL2007002789A1 (es) 2008-04-18
IL197720A0 (en) 2009-12-24

Similar Documents

Publication Publication Date Title
NO2017036I1 (no) Daklatasvir og farmasøytisk akseptable salter derav, spesielt daklatasvir dihydroklorid
CY1122687T1 (el) Συνθεσεις και μεθοδοι για την τροποποιηση της smn2 συναρμογης σε ενα υποκειμενο
NO20065878L (no) Terapeutiske forbindelser
BRPI0507224A (pt) método e dispositivo para o tratamento da apnéia obstrutiva do sono e do ronco
NO20064792L (no) Anvendelse av rotigotin til behandling og forbinding av Parkinsons pluss syndrom.
ZA200900228B (en) N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
DK2023918T3 (da) Cyclosporiner til behandlingen og forebyggelse af okulære lidelser
ATE453637T1 (de) N-(aminoheteroaryl)-1h-indol-2-carboxamid- derivate sowie deren herstellung und therapeutische anwendung
ATE420639T1 (de) Antimykotische mittel
NO20062150L (no) Nye ketooksadiazolderivater som katepsinhibitorer
SE0401342D0 (sv) Therapeutic compounds
MX352516B (es) Compuestos terapeuticos.
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
NO20084282L (no) Ny krystallinsk form for (5S)-5-[4-(5-klorpyridin-2-yloksy)piperidin-1-sulfonylmetyl]-5-metylimidazolin-2,4-dion(l) og mellomprodukter derav
CY1110170T1 (el) Ν-καρβαμοϋλμεθυλ-4(-r)-φαινυλ-2-πυρρολιδινονη, μεθοδος παρασκευης της και φαρμακευτικη χρηση αυτης
MX2010003989A (es) Composicion zibotentan que contiene mannitol y/o celulosa microcristalina.
NO20092634L (no) Fremgangsmate for fremstilling av piperazinyl og diazepanyl benzamidderivater
EA201001857A1 (ru) Фармацевтическая лекарственная форма для немедленного высвобождения производного индолинона
MX2019002615A (es) Formas cristalinas de un inhibidor tipo lisil oxidasa 2 y metodos de realizacion.
EP4027935A4 (en) LINGUAL POSITIONING DEVICE FOR SLEEP, BREATHING, JAW AND RESPIRATORY TRACT DISORDERS
PE20211818A1 (es) Composicion farmaceutica para administracion oral que comprende derivado de aminopirimidina o su sal
RU2007122391A (ru) S-миртазапин для лечения приливов
MX2009003299A (es) [2-(6-fluor-1h-indol-3-ilsulfanil)bencil]metilamina para el tratamiento de trastornos afectivos.
MX2009003974A (es) N-(2-hidroxietil)-n-metil-4-(quinolin-8-il(1-(tiazol-4-ilmetil)pi peridin-4-ilideno)metil)benzamida, el proceso para su sintesis, asi como su uso para el tratamiento del dolor, la ansiedad y la depresion.
NO20082130L (no) 3-Amino-1-arylpropylindoler og aza-substituerte indoler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application